| All Patients | Severe CAP | ||||
---|---|---|---|---|---|---|
Favorable Outcome†(n = 63) | Unfavorable Outcome†(n = 31) | p-value | Favorable Outcome†(n = 25) | Unfavorable Outcome†(n = 25) | p-value | |
Age, y | 65.6 ± 18.5 | 77.9 ± 11.8 | <.001* | 65.5 ± 15.7 | 76.4 ± 11.7 | .008* |
Gender (Female) | 25 (39.7) | 12 (38.7) | .93 | 9 (36) | 9 (36) | 1 |
Comorbid conditions: | Â | Â | .04* | Â | Â | .65 |
None | 22 (34.9) | 4 (12.9) | Â | 6 (24) | 3 (12) | |
Single | 25 (39.7) | 13 (41.9) | Â | 10 (40) | 11 (44) | |
Multiple | 16 (25.4) | 14 (45.2) | Â | 9 (36) | 11 (44) | |
Prior antibiotic therapya | 29 (46) | 14 (45.2) | .94 | 10 (40) | 11 (44) | .77 |
ECOG ≥2b | 31 (49.2) | 23 (74.2) | .02* | 11 (44) | 7 (28) | .24 |
Enteral tube feeding | 5 (7.9) | 4 (12.9) | .47 | 3 (12) | 3 (12) | 1 |
HCAPc | 20 (31.7) | 10 (32.3) | .96 | 11 (44) | 7 (28) | .24 |
Pleural effusion | 7 (11.1) | 4 (12.9) | 1 | 0 | 3 (12) | .23 |
Albumin, g/dL | 3 ± 0.5 | 2.9 ± 0.6 | .24 | 2.9 ± 0.5 | 2.8 ± 0.7 | .84 |
Globulin, g/dL | 3.9 ± 0.6 | 3.7 ± 0.9 | .26 | 3.7 ± 0.6 | 3.6 ± 1 | .79 |